These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37026512)
1. STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis. An HJ; Gwon MG; Gu H; Bae S; Leem J; Lee JB; Park KK Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026512 [TBL] [Abstract][Full Text] [Related]
2. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis. Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157 [TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice. He F; Li WN; Li XX; Yue KY; Duan JL; Ruan B; Liu JJ; Song P; Yue ZS; Tao KS; Wang L Theranostics; 2022; 12(4):1816-1828. PubMed ID: 35198075 [No Abstract] [Full Text] [Related]
4. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo. Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376 [TBL] [Abstract][Full Text] [Related]
5. Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice. Li YT; He B; Wang YZ; Wang J Respir Res; 2009 Aug; 10(1):79. PubMed ID: 19706153 [TBL] [Abstract][Full Text] [Related]
6. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line. Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line. Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo. Wang T; Li QH; Hao GP; Zhai J Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956 [TBL] [Abstract][Full Text] [Related]
10. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. Mehta M; Paudel KR; Shukla SD; Allam VSRR; Kannaujiya VK; Panth N; Das A; Parihar VK; Chakraborty A; Ali MK; Jha NK; Xenaki D; Su QP; Wich PR; Adams J; Hansbro PM; Chellappan DK; Oliver BGG; Dua K J Control Release; 2021 Sep; 337():629-644. PubMed ID: 34375688 [TBL] [Abstract][Full Text] [Related]
11. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020 [TBL] [Abstract][Full Text] [Related]
12. [An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell]. Hao TZ; Liang HP; Lv FL; Xu X; Guo H; Wang FL; Yang WJ; Luo Y; Li L Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):175-8. PubMed ID: 12921625 [TBL] [Abstract][Full Text] [Related]
13. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides. Isomura I; Morita A Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140 [TBL] [Abstract][Full Text] [Related]
14. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy. Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904 [TBL] [Abstract][Full Text] [Related]
15. Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation. Wijagkanalan W; Kawakami S; Higuchi Y; Yamashita F; Hashida M J Control Release; 2011 Jan; 149(1):42-50. PubMed ID: 20035809 [TBL] [Abstract][Full Text] [Related]
16. LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation. Liu X; Yin S; Chen Y; Wu Y; Zheng W; Dong H; Bai Y; Qin Y; Li J; Feng S; Zhao P Mol Med Rep; 2018 Apr; 17(4):5484-5491. PubMed ID: 29393460 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis. Imbaby S; Matsuda N; Tomita K; Hattori K; Palikhe S; Yokoo H; Hattori Y Sci Rep; 2020 Sep; 10(1):15316. PubMed ID: 32943679 [TBL] [Abstract][Full Text] [Related]
18. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription. Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR Front Immunol; 2019; 10():1253. PubMed ID: 31231385 [TBL] [Abstract][Full Text] [Related]
19. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model. Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line. Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]